Deadlines for...
Early Bird Registration Fees: September 17th
Short Oral Presentations Submission: September 17th
Award Submission: September 17th
Poster Presentations Submission: October 15th
News
Dr. Carmelo Scarpignato Wins ISM Best Scientific Contribution 2024 for Research on Drug Effects and Gut Microbiota
We are pleased to announce that Dr. Carmelo Scarpignato, United Campus of Malta & Chines...
Read moreBac3Gel Win Targeting Microbiota 2024 Best Short Oral Presentation (1)
Congratulations to Victoria Navas from Bac3Gel, Portugal, for winning the Best Short Oral Present...
Read moreISM Best Short Oral 2024 (2): Impact of Radio-Chemotherapy on Intestinal Dysbiosis in Cervical Cancer Patients
Congratulations to Ksenia Klimov-Kravtchenko and her team from the University of Guadalajara, Mex...
Read moreISM Best Poster 2024 (2): Indoxyl Sulfate's Role in Dyslipidemia and Cholesterol Gene Expression
We are pleased to announce that Mateusz Szudzik from the Medical University of Warsaw, Poland, has won the Best Poster Presen...
Read moreISM Best Poster 2024 (1): Exploring the Mycobiome in Autism Spectrum Disorder
Congratulations to Vlasta Demeckova and her team from Pavol Jozef Safarik University and the University of Ve...
Read moreDrug Effects of Gut Microbiota in Humans: Clinical Consequences
It is a great pleasure to welcome Prof. Carmelo Scarpignato, Chinese University of Hong Kong, China, to Targeting Microb...
Read morePhage Therapy: A New Era of “Old” Concept for “Microbiome” Health
Dr. Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia, will join Targeting Microbiota 2024 this October will share...
Read moreDoes the Microbiome Control Cravings and Addictive Behavior of their Host: A New Prospective and Hope for Treating Addiction
It is a great pleasure to welcome Dr. Steven R. Gundry, Medical Director at The Centers for Restorative Medicine, USA,&n...
Read moreCulturing the Complexity of Intestinal Microbiota In-Vitro in Bac3Gel®
Dr. Daniela Pacheco, CTO and Founder of Bac3Gel, Portugal, will share her latest research during Targeting Microbiota 2024 th...
Read moreUsing Roseoflavin, a Natural Riboflavin Analogue, to Modify the Human Microbiota
The ISM is pleased to welcome Prof. Markus Egert, active member of the ISM scientific board, from Furtwangen University...
Read moreProspects for Leveraging the Microbiota as Medicine for Hypertension
The ISM is pleased to announce that Dr. Bina Joe, Eidtor-in-Chief of Microbiota and Host, from the University of Toledo, USA...
Read moreGut Microbiome, Obesity and Diabetes
Prof. Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan, will join Targeting Microbiota 2024 this October to...
Read moreGut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
The ISM is pleased to welcome Prof. José Manuel Fernández-Real, Universitat de Girona, Spain join Targeting Microbi...
Read moreMythbusting Our Microbiome
Prof. Alan Walker, University of Aberdeen, United Kindgom, will join Targeting Microbiota 2024 this October to give a present...
Read moreFrom Microbiomes and (Meta)genomes to the Lab and Back - Identification, Production and Application of Bacteriocins
The ISM is pleased to announce that Dr. Christian Riedel, University of Ulm, Germany, will be speaking at Targeting Microbiot...
Read moreDeciphering the role of the Oral-Placental and Vaginal-Placental Microbiome Axes in Preterm Birth
The ISM is pleased to announce that Dr. Souhaila Al Khodor, Sidra Medicine, Qatar, will be speaking at Targeting Microbiota 2...
Read moreGut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes
Dr. Rochellys Diaz Heijtz, Karolinska Institutet, Sweden, will share her latest research during Targeting Microbiota 2024 thi...
Read moreMale Fertility and Gut Microbiota: Current Knowledge and Future Directions
Prof. Cristian O'Flaherty from McGill University, Canada, will join Targeting Microbiota 2024 this October to present his lat...
Read moreThe Small Intestinal Microbiota: A Hidden Player in Human Health and Disease
The ISM is excited to announce that Dr. Pascale Vonaesch from the University of Lausanne, Switzerland, will be speaking at Ta...
Read moreBacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy
Dr. Martin Loessner, ETH Zurich, Switzerland, will share his latest research during Targeting Microbiota 2024 this October. ...
Read moreMicrobial Phenotypes in Obesity: Implications for Precision Nutrition
The ISM is pleased to welcome Prof. Ellen Blaak, Maastricht University, Netherlands join Targeting Microbiota 2024 ...
Read moreProbiotics & Health: How to Select the Right Strain?
Prof. Andreas Schwiertz, from the Institute of Microecology and member of the ISM scientific board, Germany, will join Target...
Read moreSophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease
Dr. Koen Venema, Editor-in-chief of Beneficial Microbes from The Netherlands, will join Targeting Microbiota 2024 this Octobe...
Read moreThe Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health
Prof. Marvin Edeas, chairman of the ISM Scientific Board from Institut Cochin, INSERM U1016, Université de Paris, France will...
Read more- 1
- 2
- 3
Microbiota in the Press & Media
- 1
- 2
- 3